Interferon Gamma Release Assays for the Diagnosis of Latent TB Infection in HIV-Infected Individuals in a Low TB Burden Country

Autor: Nahla El-Eraki, Cliona Ni Cheallaigh, Susan Clarke, I. Fitzgerald, Jacinta Grace, Noel Gibbons, Gurmit Jagjit Singh, Colm Bergin, Thomas R. Rogers, Joseph Keane
Rok vydání: 2013
Předmět:
Bacterial Diseases
CD4-Positive T-Lymphocytes
Male
Health Screening
HIV opportunistic infections
QUANTIFERON-TB GOLD
Human immunodeficiency virus (HIV)
lcsh:Medicine
HIV Infections
medicine.disease_cause
0302 clinical medicine
Hiv infected
Prevalence
Interferon gamma
030212 general & internal medicine
lcsh:Science
0303 health sciences
Multidisciplinary
Latent tuberculosis
Middle Aged
Clinical Laboratory Sciences
3. Good health
Medicine
Infectious diseases
Female
Public Health
Interferon-gamma Release Tests
Viral load
Research Article
Test Evaluation
medicine.drug
Adult
Tuberculosis
Viral diseases
Interferon-gamma
03 medical and health sciences
Diagnostic Medicine
Latent Tuberculosis
medicine
Humans
Aged
Tuberculin Test
030306 microbiology
business.industry
lcsh:R
Tropical Diseases (Non-Neglected)
HIV
bacterial infections and mycoses
medicine.disease
Virology
CD4 Lymphocyte Count
Immunology
lcsh:Q
Clinical Immunology
business
Zdroj: PLoS ONE
PLoS ONE, Vol 8, Iss 1, p e53330 (2013)
ISSN: 1932-6203
Popis: Background Interferon gamma release assays (IGRAs) are used to diagnose latent tuberculosis infection. Two IGRAs are commercially available: the Quantiferon TB Gold In Tube (QFT-IT) and the T-SPOT.TB. There is debate as to which test to use in HIV+ individuals. Previous publications from high TB burden countries have raised concerns that the sensitivity of the QFT-IT assay, but not the T-SPOT.TB, may be impaired in HIV+ individuals with low CD4+ T-cell counts. We sought to compare the tests in a low TB burden setting. Methodology/Principal Findings T-SPOT.TB, QFT-IT, and tuberculin skin tests (TST) were performed in HIV infected individuals. Results were related to patient characteristics. McNemar’s test, multivariate regression and correlation analysis were carried out using SPSS (SPSS Inc). 256 HIV infected patients were enrolled in the study. The median CD4+ T-cell count was 338 cells/µL (range 1–1328). 37 (14%) patients had a CD4+ T-cell count of
Databáze: OpenAIRE